Highlights DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Delayed Deutsche Boerse AG Other stock markets 03:09:52 2024-05-03 am EDT			5-day change	1st Jan Change
0.9 ^EUR	+3.45%		+26.76%	+71.43%

Mar. 27	Transcript : DURECT Corporation, Q4 2023 Earnings Call, Mar 27, 2024
Mar. 27	DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DURECT Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Earnings Flash (DRRX) DURECT CORPORATION Posts Q4 Revenue $2.7M, vs. Street Est of $2.7M	Mar. 27	MT
DURECT Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 27	CI
DURECT Corporation and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for Alzet® Product Line in U.S. and Canada	Mar. 04	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q3 Revenue $1.7M, vs. Street Est of $2.5M	Nov. 13	MT
DURECT Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis with Promising Effect on Mortality	Nov. 07	CI
Durect Corporation Announces Last Patient Last Visit in Phase 2B Ahfirm Trial of Larsucosterol in Alcohol-Associated Hepatitis	23-09-07	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q2 Revenue $2.1M, vs. Street Est of $3.2M	23-08-09	MT
DURECT Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-09	CI
DURECT Corporation Completes Enrollment in Phase 2b AHFIRM Trial of Larsucosterol in Alcohol-Associated Hepatitis	23-06-07	CI
DURECT Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-08	CI
Earnings Flash (DRRX) DURECT CORPORATION Posts Q1 Revenue $2.1M	23-05-08	MT
DURECT Corporation Announces Peer-Reviewed Article Accepted for Publication with Additional Data from Previously Completed Phase 2A Study of Larsucosterol in Alcohol-Associated Hepatitis	23-04-10	CI
Earnings Flash (DRRX) DURECT CORPORATION Reports Q4 Revenue $3.3M, vs. Street Est of $3.5M	23-03-07	MT
DURECT Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-07	CI
Reverse Split: 1 of 10	22-12-05	FA
DURECT to Implement 1-for-10 Reverse Stock Split	22-11-29	MT
Earnings Flash (DRRX) DURECT CORPORATION Reports Q3 Revenue $12M, vs. Street Est of $13M	22-11-02	MT
DURECT Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Highlights

Filters